Steffen Thirstrup, formerly with the Danish Health and Medicines Authority, has joined the regulatory advisory board of the NDA Group, the regulatory consultancy. Professor Thirstrup is currently adjunct professor at the School of Pharmacy, Faculty of Health Sciences at the University of Copenhagen. Previously, he was head of the medicines assessment and clinical trials division at the Danish agency.
NDA announced the appointment on 6 June 2013.
Copyright 2013 Evernow Publishing Ltd